mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
6e-19 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
1e-16 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.29 |
4e-15 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-10 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.27 |
3e-09 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.28 |
4e-09 |